speaker-icon

Latest Posts

Partex-EDCC-collaboration-illustration

3

Jun 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

featured, Press release 2024
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More
Partex-Lupin-press-release-illustration

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

featured, Press release 2024
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
german-blockchain

German Blockchain, AI Platform to ‘Democratize’ Drug Development

Germany-based company Innoplexus AG said that iPlexus (one of its subsidiaries) will leverage blockchain technology and AI to resolve inefficiencies in early-stage drug discovery.

The company also has its offices in Pune, India and Hoboken in the United States of America.

The subsidiary will give researchers a secure, blockchain-and-AI-based platform for publishing and extending license to use unpublished data from successful and failed experiments. IP will be secured on the blockchain with an immutable timestamp, and AI will analyze all uploaded data to determine its value for ongoing drug development research.

The company in a statement said, all the unpublished data will also be available alongside the published data.

The Chief Executive Officer (CEO) and co-founder Gunjan Bhardwaj said, “Our mission at Innoplexus is to democratize the drug discovery process. We believe that cutting-edge technologies like AI and blockchain are the key to making this possible. After over 6 months of research, we believe that the new iPlexus is a major step forward for the preclinical trial industry and will solve many of the problems that are slowing the industry down. By overcoming these challenges, we will make drug discovery more efficient and bring down the consumer price of drugs.”

This technology update came soon on the heels of a recent study conducted by the company which said consumer perceptions of the pharma industry continue to be negative, with only 20% of consumers reporting a positive view of pharmaceutical companies. However, 64% said that their opinion of the industry would improve if drug prices were reduced.

The original article was published on Crypto News.

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing anavex_partex_partnership_Innoplexus
on June 27, 2023

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…

Read More